FDA shuts 4 food units at Morjim
Panaji:
The directorate of food and drugs administration (FDA) directed four premises in Morjim to shut down due to unhygienic operations.
The FDA inspected 21 premises in Morjim and two were fined Rs 2,000 and Rs 3,000 for using newspapers to wrap food.
Thirteen food operators were served improvement notices with directions to comply within 14 days.
The FDA also fined M/s Bhakshi Hotel in Khareband, Salcete, Rs 20,000 for non-compliance with deficiencies noted during the June 6 inspection.
The team also reinspected Janta Hotel, Margao, and found most issues resolved, except for the use of food colour. The hotel was directed to discard the item and ensure full compliance. During the reinspection of Dalima Bakery, Colva, the FDA found that deficiencies in the earlier inspection report were not fully complied with.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Aakaar Medical Technologies IPO: Check issue size, price band and other details
The initial public offering (IPO) of aesthetic healthcare product maker Aakaar Medical Technologies Limited opens for subscription today, June 20, and will close on June 24, 2025. The company is looking to raise Rs 27 crore through a fresh issue of 37.5 lakh equity shares, with the shares set to list on NSE SME on June 27, subject to allotment finalisation on June 25. The price band for the IPO is Rs 68 to Rs 72 per share, and investors can bid for a minimum lot size of 1,600 shares. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Elegant New Scooters For Seniors In 2024: The Prices May Surprise You Mobility Scooter | Search Ads Learn More Undo Ahead of the IPO, the company has raised Rs 7.68 crore from anchor investors by allocating 10.67 lakh shares on June 19. The issue has been structured with 47.42% reserved for qualified institutional buyers (QIBs), 14.29% for non-institutional investors (NIIs), and 33.26% for retail investors. Indorient Financial Services is acting as the book-running lead manager, while Bigshare Services is the registrar to the issue. Alacrity Securities is the designated market maker. Founded in 2013, Aakaar Medical Technologies operates in the medical aesthetics space, supplying dermatology and cosmetic products to physicians, surgeons, and cosmetologists. Its product mix includes skin care, hair care, injectables, laser and aesthetic devices, and home-use products, including solutions for hair loss and pigmentation. Live Events The company distributes both domestically manufactured and imported products from countries like South Korea, Spain, Italy, and Austria, with a presence in over 15 Indian states. It has a dedicated team of 90 sales and service professionals. Financially, Aakaar reported a 33% increase in revenue to Rs 61.76 crore and 110% jump in net profit to Rs 6.04 crore in FY25. The IPO proceeds will be used primarily to meet working capital requirements and for general corporate purposes.
Hans India
2 hours ago
- Hans India
On Rahul Gandhi's b'day, Jagga Reddy extends `10 lakh assistance to a cancer patient
Hyderabad: To mark senior party leader and the Leader of Opposition Rahul Gandhi's birthday, TPCC working president T Jagga Reddy on Thursday extended Rs 10 lakh financial assistance to a cancer patient, Hari Krishna Prasad, of Thallapalli village in Sangareddy constituency. Prasad has been suffering from cancer for some time now. As he comes from a poor family, Reddy provided aid for his full treatment. As Prasad was earning just Rs 13,000 per month and could not afford a costly battle against cancer, the Congress leader came forward to support Prasad, who works as an employee in a Gurukula school. He has a wife, Shailaja, a daughter studying in LKG, and a son in first grade. Prasad was diagnosed with cancer three months ago. His family has already spent lakhs on treatment. With no money left for further medical expenses, the family was left helpless. Reddy came to know about Prasad's situation through his followers. Moved by the plight, Reddy volunteered to bear the complete cost of the treatment. He handed over Rs 10 lakh assistance to the patient on Thursday. Reddy reassured Prasad and his family of his support and encouraged them to stay strong. He also promised to facilitate help through the Chief Minister's Relief Fund to cover the treatment expenses incurred so far. Prasad's family expressed heartfelt gratitude for Reddy's support.
Time of India
4 hours ago
- Time of India
State govt puts cap of Rs 600 again for dengue test
1 2 3 Pune: The state govt has again capped the price of ELISA test for dengue at Rs 600 while issuing fresh directives to all hospitals and laboratories amid a rise in vector-borne infections like dengue and chikungunya this monsoon. The rate has remained unchanged since 2016. In 2015, Delhi became the first state to cap the rate of dengue test at Rs 600, which was then followed by Maharashtra. Pune Municipal Corporation officials have urged patients to lodge a complaint in case any hospital or laboratory is found to be charging more than the capped amount. The state health department has been telling diagnostic labs and hospitals since 2016 to cap the cost during monsoon to make these tests affordable for patients. However, it is often seen that labs overcharge anywhere between Rs800 and Rs1,100 per test, which deters patients from undergoing a proper evaluation. Dr Sandeep Sangale, joint director, health services, Maharashtra, said, "Since 2016, the state has ordered all private hospitals and labs to conduct NS1 ELISA and MAC ELISA dengue tests within Rs 600 to ensure that there is no exploitation of patients by these labs or hospitals. We have also instructed the labs to make sure that under no circumstances do they use rapid diagnostic kits to test dengue samples and stick to ELISA tests only for confirming dengue. We have sent the circular to all directors under the health department and the concerned medical officers in civic bodies and zilla parishads as well." Confirming the same, Dr Nina Borade, chief health officer, PMC health department, said, "We have received the circular and issued a notification to all the private labs and hospitals registered with us to ensure that they do not charge more than Rs 600 for a dengue ELISA test. We also urge citizens to come forward if they find any lab or hospital charging more than the stipulated amount. During monsoon we see a surge in the number of cases and so the govt has capped the prices to make sure that everyone can afford these tests, which are important for determining the course of treatment. " Borade said that citizens can mail their complaints to health@ or contact the department on 020- 25501215 Meanwhile, Indian Medical Association (IMA) has stated that while most members do comply with the govt guidelines, there is disagreement among some regarding the capping. Dr Sanjay Patil, chairperson, Hospital Board of India, IMA Pune chapter, said, "The feasibility of any cost for any diagnostic test or procedure depends on the material used and the infrastructure involved. Every hospital or a diagnostic center has the freedom to decide the rate for the investigation but considering that dengue is prevalent in Pune and for the time being the govt has put these restrictions, so all private hospitals are following the govt guidelines. However there is some unrest among the hospitals on price capping which has remained the same since 2016." On Wednesday, TOI reported that an early monsoon had triggered a surge in vector-borne infections in the state as the number of cases has surpassed those reported in 2024 for the first six months. Pune also has seen a surge in the number of vector-borne infections. Altogether 169 suspected and eight confirmed dengue cases have been reported this year of which 62 suspected and two confirmed were reported in May and June (till 18). Also, eight chikungunya cases have been reported in Pune city this year. Pune: The state govt has again capped the price of ELISA test for dengue at Rs 600 while issuing fresh directives to all hospitals and laboratories amid a rise in vector-borne infections like dengue and chikungunya this monsoon. The rate has remained unchanged since 2016. In 2015, Delhi became the first state to cap the rate of dengue test at Rs 600, which was then followed by Maharashtra. Pune Municipal Corporation officials have urged patients to lodge a complaint in case any hospital or laboratory is found to be charging more than the capped amount. The state health department has been telling diagnostic labs and hospitals since 2016 to cap the cost during monsoon to make these tests affordable for patients. However, it is often seen that labs overcharge anywhere between Rs800 and Rs1,100 per test, which deters patients from undergoing a proper evaluation. Dr Sandeep Sangale, joint director, health services, Maharashtra, said, "Since 2016, the state has ordered all private hospitals and labs to conduct NS1 ELISA and MAC ELISA dengue tests within Rs 600 to ensure that there is no exploitation of patients by these labs or hospitals. We have also instructed the labs to make sure that under no circumstances do they use rapid diagnostic kits to test dengue samples and stick to ELISA tests only for confirming dengue. We have sent the circular to all directors under the health department and the concerned medical officers in civic bodies and zilla parishads as well." Confirming the same, Dr Nina Borade, chief health officer, PMC health department, said, "We have received the circular and issued a notification to all the private labs and hospitals registered with us to ensure that they do not charge more than Rs 600 for a dengue ELISA test. We also urge citizens to come forward if they find any lab or hospital charging more than the stipulated amount. During monsoon we see a surge in the number of cases and so the govt has capped the prices to make sure that everyone can afford these tests, which are important for determining the course of treatment. " Borade said that citizens can mail their complaints to health@ or contact the department on 020- 25501215 Meanwhile, Indian Medical Association (IMA) has stated that while most members do comply with the govt guidelines, there is disagreement among some regarding the capping. Dr Sanjay Patil, chairperson, Hospital Board of India, IMA Pune chapter, said, "The feasibility of any cost for any diagnostic test or procedure depends on the material used and the infrastructure involved. Every hospital or a diagnostic center has the freedom to decide the rate for the investigation but considering that dengue is prevalent in Pune and for the time being the govt has put these restrictions, so all private hospitals are following the govt guidelines. However there is some unrest among the hospitals on price capping which has remained the same since 2016." On Wednesday, TOI reported that an early monsoon had triggered a surge in vector-borne infections in the state as the number of cases has surpassed those reported in 2024 for the first six months. Pune also has seen a surge in the number of vector-borne infections. Altogether 169 suspected and eight confirmed dengue cases have been reported this year of which 62 suspected and two confirmed were reported in May and June (till 18). Also, eight chikungunya cases have been reported in Pune city this year.
